# Reference data sources for skibidy validation
#
# Each dataset lists the papers it was synthesized from, with full citations
# and DOI/PMC links.
#
# Directory structure:
#   raw/       Per-paper digitized data (one CSV per source, with figure reference)
#   consensus/ Synthesized midpoints used by comparison scripts
#
# Wound model: 4-6mm punch biopsy, moist wound care, healthy adult skin.

closure_kinetics_punch_biopsy:
  description: Re-epithelialization trajectory (% wound closure over 28 days)
  consensus: consensus/closure_kinetics_punch_biopsy.csv
  raw_files:
    - raw/closure/eaglstein1978_closure.csv
    - raw/closure/cukjati2000_closure.csv
    - raw/closure/pastar2014_closure.csv
  columns: [day, closure_pct]
  units: {day: days, closure_pct: percent}
  normalization: absolute (0-100%)
  sources:
    - id: eaglstein1978
      authors: Eaglstein WH, Mertz PM
      year: 1978
      title: "New methods for assessing epidermal wound healing"
      journal: J Invest Dermatol 71(6):382-384
      doi: 10.1111/1523-1747.ep12556814
    - id: cukjati2000
      authors: Cukjati D, Rebersek S, Karba R, Miklavcic D
      year: 2000
      title: "Modelling of chronic wound healing dynamics"
      journal: Med Biol Eng Comput 38(3):339-347
      doi: 10.1007/BF02347056
    - id: pastar2014
      authors: Pastar I, Stojadinovic O, Yin NC, Ramirez H, Nusbaum AG, Sawaya A, Patel SB, Khalid L, Isseroff RR, Tomic-Canic M
      year: 2014
      title: "Epithelialization in wound healing: a comprehensive review"
      journal: Adv Wound Care 3(7):445-464
      doi: 10.1089/wound.2013.0473

inflammation_timecourse:
  description: Composite inflammatory signal (cytokines + cell density), peak-normalized
  consensus: consensus/inflammation_timecourse.csv
  raw_files:
    - raw/inflammation/eming2007_inflammation.csv
    - raw/inflammation/kondo1996_inflammation.csv
    - raw/inflammation/hubner1996_inflammation.csv
  columns: [day, inflammation_normalized]
  units: {day: days, inflammation_normalized: fraction of peak}
  normalization: peak-normalized (1.0 = maximum at day 2)
  notes: >
    Peak reflects neutrophil density maximum and sustained TNF-alpha/IL-1/IL-6
    expression.
  sources:
    - id: eming2007
      authors: Eming SA, Krieg T, Davidson JM
      year: 2007
      title: "Inflammation in wound repair: molecular and cellular mechanisms"
      journal: J Invest Dermatol 127(3):514-525
      doi: 10.1038/sj.jid.5700701
    - id: kondo1996
      authors: Kondo T, Ohshima T
      year: 1996
      title: "The dynamics of inflammatory cytokines in the healing process of mouse skin wound"
      journal: Int J Legal Med 108(5):231-236
      doi: 10.1007/BF01369816
    - id: hubner1996
      authors: Hubner G, Brauchle M, Smola H, Madlener M, Fassler R, Werner S
      year: 1996
      title: "Differential regulation of pro-inflammatory cytokines during wound healing"
      journal: Cytokine 8(7):548-556
      doi: 10.1006/cyto.1996.0074
    - id: koh2011
      authors: Koh TJ, DiPietro LA
      year: 2011
      title: "Inflammation and wound healing: the role of the macrophage"
      journal: Expert Rev Mol Med 13:e23
      doi: 10.1017/S1462399411001943
    - id: canedo2019
      authors: Canedo-Dorantes L, Canedo-Ayala M
      year: 2019
      title: "Skin acute wound healing: a comprehensive review"
      journal: Int J Inflam 2019:3706315
      doi: 10.1155/2019/3706315

immune_cell_kinetics:
  description: Neutrophil and macrophage counts, each peak-normalized independently
  consensus: consensus/immune_cell_kinetics.csv
  raw_files:
    - raw/neutrophils/kim2008_neutrophils.csv
    - raw/neutrophils/wilgus2013_neutrophils.csv
    - raw/macrophages/krzyszczyk2018_macrophages.csv
    - raw/macrophages/rodero2010_macrophages.csv
    - raw/macrophages/lucas2010_macrophages.csv
  columns: [day, neutrophils_normalized, macrophages_normalized]
  units: {day: days, neutrophils_normalized: fraction of peak, macrophages_normalized: fraction of peak}
  normalization: peak-normalized per cell type (1.0 = maximum count)
  notes: >
    Neutrophils peak day 1 (~6x10^6 cells, Kim 2008).
    Macrophages peak day 3 (Krzyszczyk 2018, Rodero 2010).
  sources:
    - id: kim2008
      authors: Kim MH, Liu W, Borjesson DL, Curry FR, Miller LS, Cheung AL, Liu FT, Isseroff RR, Simon SI
      year: 2008
      title: "Dynamics of neutrophil infiltration during cutaneous wound healing and infection"
      journal: J Invest Dermatol 128(7):1812-1820
      doi: 10.1038/sj.jid.5701223
    - id: wilgus2013
      authors: Wilgus TA, Roy S, McDaniel JC
      year: 2013
      title: "Neutrophils and wound repair: positive actions and negative reactions"
      journal: Adv Wound Care 2(7):379-388
      doi: 10.1089/wound.2012.0383
    - id: koh2011
      authors: Koh TJ, DiPietro LA
      year: 2011
      title: "Inflammation and wound healing: the role of the macrophage"
      journal: Expert Rev Mol Med 13:e23
      doi: 10.1017/S1462399411001943
    - id: rodero2010
      authors: Rodero MP, Khosrotehrani K
      year: 2010
      title: "Skin wound healing modulation by macrophages"
      journal: Int J Clin Exp Pathol 3(7):643-653
      pmc: PMC2933384
    - id: krzyszczyk2018
      authors: Krzyszczyk P, Schloss R, Palmer A, Berthiaume F
      year: 2018
      title: "The role of macrophages in acute and chronic wound healing"
      journal: Front Physiol 9:419
      doi: 10.3389/fphys.2018.00419
    - id: lucas2010
      authors: Lucas T, Waisman A, Ranjan R, Roes J, Krieg T, Muller W, Roers A, Eming SA
      year: 2010
      title: "Differential roles of macrophages in diverse phases of skin repair"
      journal: J Immunol 184(7):3964-3977
      doi: 10.4049/jimmunol.0903356

myofibroblast_kinetics:
  description: Alpha-SMA+ myofibroblast density, peak-normalized
  consensus: consensus/myofibroblast_kinetics.csv
  raw_files:
    - raw/myofibroblasts/desmouliere1995_myofibroblasts.csv
    - raw/myofibroblasts/darby2014_myofibroblasts.csv
    - raw/myofibroblasts/tomasek2002_myofibroblasts.csv
    - raw/myofibroblasts/hinz2007_myofibroblasts.csv
  columns: [day, myofibroblasts_normalized]
  units: {day: days, myofibroblasts_normalized: fraction of peak density}
  normalization: peak-normalized (1.0 = maximum alpha-SMA+ cells at day 12)
  notes: >
    Myofibroblasts first appear day 4-6 as proto-myofibroblasts acquire alpha-SMA.
    Peak density day 10-15 during active contraction.
    Apoptosis begins ~day 12, peaks ~day 20 (Desmouliere 1995).
    Largely resolved by day 30 in normal healing.
  sources:
    - id: desmouliere1995
      authors: Desmouliere A, Redard M, Darby I, Gabbiani G
      year: 1995
      title: "Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar"
      journal: Am J Pathol 146(1):56-66
      pmc: PMC1870783
    - id: darby2014
      authors: Darby IA, Laverdet B, Bonte F, Desmouliere A
      year: 2014
      title: "Fibroblasts and myofibroblasts in wound healing"
      journal: Clin Cosmet Investig Dermatol 7:301-311
      doi: 10.2147/CCID.S50046
    - id: tomasek2002
      authors: Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA
      year: 2002
      title: "Myofibroblasts and mechano-regulation of connective tissue remodelling"
      journal: Nat Rev Mol Cell Biol 3(5):349-363
      doi: 10.1038/nrm809
    - id: hinz2007
      authors: Hinz B
      year: 2007
      title: "Formation and function of the myofibroblast during tissue repair"
      journal: J Invest Dermatol 127(3):526-537
      doi: 10.1038/sj.jid.5700613
    - id: statpearls_wound
      authors: Wound Healing Phases, StatPearls
      year: 2024
      title: "Wound Healing Phases"
      journal: StatPearls (NBK470443)
      url: https://www.ncbi.nlm.nih.gov/books/NBK470443/

collagen_deposition:
  description: Collagen accumulation during proliferative/remodeling phases, end-normalized
  consensus: consensus/collagen_deposition.csv
  raw_files:
    - raw/collagen/gonzalez2016_collagen.csv
    - raw/collagen/zhou2013_collagen.csv
    - raw/collagen/mathew2021_collagen.csv
    - raw/collagen/caetano2016_collagen.csv
  columns: [day, collagen_normalized]
  units: {day: days, collagen_normalized: fraction of day-28 value}
  normalization: end-normalized (1.0 = collagen at day 28)
  notes: >
    Collagen deposition begins day 5-7, rises through proliferative phase,
    continues actively for 4-5 weeks. Tensile strength as proxy:
    week 1 ~3%, week 3 ~20%, 3 months ~80%.
    This represents the rising phase of a curve that plateaus at ~80% over months.
  sources:
    - id: gonzalez2016
      authors: Gonzalez ACDO, Costa TF, Andrade ZA, Medrado ARAP
      year: 2016
      title: "Wound healing: a literature review"
      journal: An Bras Dermatol 91(5):614-620
      doi: 10.1590/abd1806-4841.20164741
    - id: statpearls_wound
      authors: Wound Healing Phases, StatPearls
      year: 2024
      title: "Wound Healing Phases"
      journal: StatPearls (NBK470443)
      url: https://www.ncbi.nlm.nih.gov/books/NBK470443/
    - id: zhou2013
      authors: Zhou S, Salisbury J, Preedy VR, Emery PW
      year: 2013
      title: "Increased collagen synthesis rate during wound healing in muscle"
      journal: PLoS One 8(3):e58324
      doi: 10.1371/journal.pone.0058324
    - id: mathew2021
      authors: Mathew-Steiner SS, Roy S, Sen CK
      year: 2021
      title: "Collagen in wound healing"
      journal: Bioengineering 8(5):63
      doi: 10.3390/bioengineering8050063
    - id: caetano2016
      authors: Caetano GF, Fronza M, Leite MN, Gomes A, Frade MAC
      year: 2016
      title: "Comparison of collagen content in skin wounds"
      journal: Pharm Biol 54(11):2555-2559
      doi: 10.3109/13880209.2016.1170861

# ===========================================================================
# Diabetic wound healing validation
# Parameters for impaired healing: immune, keratinocyte, fibroblast, vascular.
# ===========================================================================

diabetic_wound_healing:
  description: >
    Literature sources validating diabetic wound model parameters.
    No digitized timeseries yet; citations support parameter magnitudes.
  sources:
    # Macrophage M1/M2 polarization (diabetic_m1_duration_factor, diabetic_resolution_factor)
    - id: mirza2011
      authors: Mirza R, Koh TJ
      year: 2011
      title: "Dysregulation of monocyte/macrophage phenotype in wounds of diabetic mice"
      journal: Cytokine 56(2):256-264
      doi: 10.1016/j.cyto.2011.06.016
      notes: >
        Diabetic mouse wounds show persistent M1 markers (iNOS, TNF-alpha) and
        delayed M2 markers (Arg1, IL-10). Supports m1_duration_factor=3.0 and
        resolution_factor=0.3.
    - id: louiselle2021
      authors: Louiselle AE, Niemiec SM, Zgheib C, Liechty KW
      year: 2021
      title: "Macrophage polarization and diabetic wound healing"
      journal: Transl Res 236:109-116
      doi: 10.1016/j.trsl.2021.05.006
      pmc: PMC9797953
      notes: >
        Review: diabetic macrophages fail M1-to-M2 switch; sustained TNF-alpha/
        IL-1/IL-6 impairs re-epithelialization.

    # Neutrophil infiltration and lifespan (diabetic_neutrophil_factor, _lifespan_factor)
    - id: wong2015
      authors: Wong SL, Demers M, Martinod K, Gallant M, Wang Y, Goldenberg AB, Bhatt DL, et al.
      year: 2015
      title: "Diabetes primes neutrophils to undergo NETosis, which impairs wound healing"
      journal: Nat Med 21(7):815-819
      doi: 10.1038/nm.3887
      notes: >
        Hyperglycemia primes excessive NET release; NET-laden wounds show ~2x
        neutrophil burden vs. controls. Supports neutrophil_factor=1.8.
    - id: brem2007
      authors: Brem H, Tomic-Canic M
      year: 2007
      title: "Cellular and molecular basis of wound healing in diabetes"
      journal: J Clin Invest 117(5):1219-1222
      doi: 10.1172/JCI32169
      notes: >
        Review: neutrophil apoptosis delayed in diabetic wounds; prolonged
        protease release damages ECM. Supports neutrophil_lifespan_factor=1.5.
    - id: albaloureiro2007
      authors: Alba-Loureiro TC, Munhoz CD, Martins JO, Cerchiaro GA, Scavone C, Curi R, Sannomiya P
      year: 2007
      title: "Neutrophil function and metabolism in individuals with diabetes mellitus"
      journal: Braz J Med Biol Res 40(8):1037-1044
      doi: 10.1016/j.lfs.2006.10.001
      notes: >
        Impaired neutrophil apoptosis in diabetes; reduced caspase-3 activity
        and delayed phosphatidylserine exposure. Supports
        neutrophil_apoptosis_factor=0.3.

    # Efferocytosis (diabetic_efferocytosis_factor)
    - id: khanna2010
      authors: Khanna S, Biswas S, Shang Y, Collard E, Azad A, Kauh C, et al.
      year: 2010
      title: "Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice"
      journal: PLoS One 5(3):e9539
      doi: 10.1371/journal.pone.0009539
      notes: >
        Diabetic wound macrophages show ~50% reduction in phagocytic clearance
        of apoptotic cells. Supports efferocytosis_factor=0.5.

    # Keratinocyte proliferation and migration (diabetic_prolif_factor, _migration_factor)
    - id: wang2020
      authors: Wang Y, Graves DT
      year: 2020
      title: "Keratinocyte function in normal and diabetic wounds and modulation by FOXO1"
      journal: J Diabetes Res 2020:3714704
      doi: 10.1155/2020/3714704
      notes: >
        Hyperglycemia attenuates p125FAK phosphorylation critical for cell cycle
        progression; PI3K/Akt signaling and ClC-2 function reduced, cutting
        migration speed 40-60%. Supports prolif_factor=0.5, migration_factor=0.6.

    # Fibroblast dysfunction (diabetic_fibroblast_activation_factor, _collagen_factor, _lifespan_factor)
    - id: lerman2003
      authors: Lerman OZ, Galiano RD, Armour M, Levine JP, Gurtner GC
      year: 2003
      title: "Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia"
      journal: Am J Pathol 162(1):303-312
      pmc: PMC1851127
      notes: >
        Diabetic fibroblasts show delayed activation, reduced VEGF production,
        and impaired hypoxia response. Supports fibroblast_activation_factor=2.0,
        fibroblast_lifespan_factor=0.6.
    - id: goldberg2007
      authors: Goldberg MT, Han YP, Yan C, Shaw MC, Garner WL
      year: 2007
      title: "TNF-alpha suppresses alpha-smooth muscle actin expression in human dermal fibroblasts"
      journal: J Invest Dermatol 127(11):2645-2655
      doi: 10.1038/sj.jid.5700890
      notes: >
        Chronic TNF-alpha (as in diabetic wounds) suppresses myofibroblast
        differentiation and collagen synthesis. Supports collagen_factor=0.4.
    - id: spanheimer1988
      authors: Spanheimer RG
      year: 1988
      title: "Direct inhibition of collagen production in vitro by diabetic rat serum"
      journal: Metabolism 37(5):479-485
      doi: 10.1016/0026-0495(88)90050-9
      notes: >
        Collagen synthesis fell to ~58% of control in diabetic serum; dose-dependent
        inhibition by diabetic rat serum factors. Supports collagen_factor=0.4.

    # Microangiopathy (perfusion_basal, perfusion_angio_rate)
    - id: dinh2005
      authors: Dinh T, Veves A
      year: 2005
      title: "A review of the mechanisms implicated in the pathogenesis of the diabetic foot"
      journal: Int J Low Extrem Wounds 4(3):154-159
      doi: 10.1177/1534734605280130
      notes: >
        Capillary density -22%, lumen area -58% in diabetic foot skin.
        Supports perfusion_basal=0.7.
    - id: brem2016
      authors: Brem H, Sheehan P, Rosenberg HJ, Schneider JS, Boulton AJ
      year: 2006
      title: "Evidence-based protocol for diabetic foot ulcers"
      journal: Plast Reconstr Surg 117(7 Suppl):193S-209S
      doi: 10.1097/01.prs.0000225459.93750.29
      notes: >
        Review: impaired VEGF/FGF signaling slows angiogenesis. Reduced NO
        bioavailability further limits vessel formation.
        Supports perfusion_angio_rate=0.002 (vs. normal 0.005).

    # Water / barrier dysfunction (water_recovery_rate)
    - id: sakai2005
      authors: Sakai S, Kikuchi K, Satoh J, Tagami H, Inoue S
      year: 2005
      title: "Functional properties of the stratum corneum in patients with diabetes mellitus: similarities to senile xerosis"
      journal: Br J Dermatol 153(2):319-323
      doi: 10.1111/j.1365-2133.2005.06756.x
      notes: >
        Diabetic patients show reduced stratum corneum hydration (lower HFC) and
        decreased sebaceous gland activity vs. controls. Supports compound
        reduction in water_recovery_rate (0.05 -> 0.02).
    - id: li2017
      authors: Li X, Xu J, He Y, Yang Y, Huang L, et al.
      year: 2017
      title: "Diabetic and sympathetic influences on the water permeability barrier function of human skin as measured using transepidermal water loss"
      journal: Medicine 96(45):e8611
      doi: 10.1097/MD.0000000000008611
      notes: >
        Diabetic skin shows altered water permeability barrier function related
        to peripheral sympathetic neuropathy. Reduced TEWL on distal limbs
        indicates impaired barrier homeostasis.

    # Chronic baseline inflammation (diabetic_baseline_inflammation)
    - id: dinh2012
      authors: Dinh T, Tecilazich F, Kafanas A, Doupis J, Gnardellis C, Leal E, et al.
      year: 2012
      title: "Mechanisms involved in the development and healing of diabetic foot ulceration"
      journal: Diabetes 61(11):2937-2947
      doi: 10.2337/db12-0227
      notes: >
        Elevated baseline IL-1beta, TNF-alpha, IL-6 in diabetic serum
        even before wounding (AGE/RAGE pathway).
    - id: bierhaus2005
      authors: Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, et al.
      year: 2005
      title: "Understanding RAGE, the receptor for advanced glycation end products"
      journal: J Mol Med 83(11):876-886
      doi: 10.1007/s00109-005-0688-7
      notes: >
        RAGE-NF-kB axis produces sustained constitutive inflammation in diabetic
        tissue; AGE accumulation drives persistent cytokine production independent
        of acute injury. Supports baseline_inflammation=0.001.

    # Inflammation sensitivity (diabetic_inflammation_sensitivity)
    - id: rasik2000
      authors: Rasik AM, Shukla A
      year: 2000
      title: "Antioxidant status in delayed healing type of wounds"
      journal: Int J Exp Pathol 81(4):257-263
      doi: 10.1046/j.1365-2613.2000.00158.x
      notes: >
        Diabetic wound tissue shows ~50% reduced SOD and catalase activity,
        making keratinocytes more vulnerable to oxidative damage from
        equivalent inflammation levels. Supports inflammation_sensitivity=2.0.
    - id: lobmann2002
      authors: Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H
      year: 2002
      title: "Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients"
      journal: Diabetologia 45(7):1011-1016
      doi: 10.1007/s00125-002-0868-8
      notes: >
        MMP-1 65-fold and MMP-9 14-fold elevated in diabetic foot ulcers vs.
        traumatic wounds; TIMP-2 reduced. Elevated MMPs degrade growth factors
        (EGF, PDGF, TGF-beta) at the wound bed, amplifying the effective
        impact of inflammation on keratinocyte function.
        Supports inflammation_sensitivity=2.0.
    - id: brownlee2005
      authors: Brownlee M
      year: 2005
      title: "The pathobiology of diabetic complications: a unifying mechanism"
      journal: Diabetes 54(6):1615-1625
      doi: 10.2337/diabetes.54.6.1615
      notes: >
        Unifying mechanism: hyperglycemia-driven mitochondrial superoxide
        overproduction activates four major damage pathways (polyol, AGE,
        PKC, hexosamine). Provides mechanistic basis for increased
        keratinocyte sensitivity to inflammatory mediators.

# ===========================================================================
# Diabetic wound healing timeseries (validation reference curves)
# Derived from normal curves scaled by literature factors (see sources below).
# ===========================================================================

diabetic_closure_kinetics:
  description: >
    Diabetic wound closure trajectory, scaled from normal punch biopsy
    consensus using murine db/db data. 1.8x overall time-stretch with
    steeper delay in early phase (~3x at day 3-7) and convergence in
    late phase (~1.5x at day 14-21).
  consensus: consensus/diabetic_closure_kinetics.csv
  columns: [day, closure_pct]
  units: {day: days, closure_pct: percent}
  normalization: absolute (0-100%)
  notes: >
    Scaling factors from Galiano 2004, Michaels 2007: db/db mice complete
    healing at 27.75d vs 11.86d for controls (2.3x). Day 7: 20-30% vs
    70-80% (3x early delay). Day 14: 55-70% vs 95-100%.
  sources:
    - id: galiano2004
      authors: Galiano RD, Michaels J, Dobryansky M, Levine JP, Gurtner GC
      year: 2004
      title: "Quantitative and reproducible murine model of excisional wound healing"
      journal: Wound Repair Regen 12(4):485-492
      doi: 10.1111/j.1067-1927.2004.12404.x
    - id: michaels2007
      authors: Michaels JT, Churgin SS, Blechman KM, Greives MR, Ber S, Gurtner GC
      year: 2007
      title: "db/db mice exhibit severe wound-healing impairments compared with other murine diabetic strains"
      journal: Wound Repair Regen 15(5):665-670
      doi: 10.1111/j.1524-475X.2007.00273.x
    - id: falanga2005
      authors: Falanga V
      year: 2005
      title: "Wound healing and its impairment in the diabetic foot"
      journal: Lancet 366(9498):1736-1743
      doi: 10.1016/S0140-6736(05)67700-8

diabetic_immune_cell_kinetics:
  description: >
    Diabetic wound immune cell kinetics, scaled from normal consensus.
    Neutrophils: 5x reduced early (6h), peak shifted to day 5, persistent
    through day 14+. Macrophages: 0.3-0.5x early, peak shifted to day 7,
    elevated and persistent through day 28.
  consensus: consensus/diabetic_immune_cell_kinetics.csv
  columns: [day, neutrophils_normalized, macrophages_normalized]
  units: {day: days, neutrophils_normalized: fraction of peak, macrophages_normalized: fraction of peak}
  normalization: peak-normalized per cell type (1.0 = maximum count)
  notes: >
    Neutrophil scaling from Wetzler 2000 (persistent day 13+), Clayton 2024
    (5x reduced early). Macrophage scaling from Mirza & Koh 2011 (reduced
    early, elevated late), Khanna 2010 (persistent, failed resolution).
  sources:
    - id: mirza2011
      authors: Mirza R, Koh TJ
      year: 2011
      title: "Dysregulation of monocyte/macrophage phenotype in wounds of diabetic mice"
      journal: Cytokine 56(2):256-264
      doi: 10.1016/j.cyto.2011.06.016
    - id: wetzler2000
      authors: Wetzler C, Kampfer H, Stallmeyer B, Pfeilschifter J, Frank S
      year: 2000
      title: "Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse"
      journal: J Invest Dermatol 115(2):245-253
      doi: 10.1046/j.1523-1747.2000.00029.x
    - id: khanna2010
      authors: Khanna S, Biswas S, Shang Y, Collard E, Azad A, Kauh C, et al.
      year: 2010
      title: "Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice"
      journal: PLoS One 5(3):e9539
      doi: 10.1371/journal.pone.0009539
    - id: clayton2024
      authors: Clayton SM, Shafikhani SH, Soulika AM
      year: 2024
      title: "Macrophage and neutrophil dysfunction in diabetic wounds"
      journal: Adv Wound Care 13(9):463-484
      doi: 10.1089/wound.2023.0149

diabetic_inflammation_timecourse:
  description: >
    Diabetic wound inflammation, scaled from normal consensus.
    Peak shifted from day 2 to day 3, resolution delayed >2x,
    persistent chronic baseline (~0.12 at day 28 vs 0.02 normal).
  consensus: consensus/diabetic_inflammation_timecourse.csv
  columns: [day, inflammation_normalized]
  units: {day: days, inflammation_normalized: fraction of peak}
  normalization: peak-normalized (1.0 = maximum)
  notes: >
    Cytokines 2x higher at day 10 (Mirza & Koh 2011). TNF-alpha/IL-1beta
    100x elevated in chronic wound fluid (Krzyszczyk 2018). Resolution
    fails or delayed beyond day 13-15 (Wetzler 2000, Louiselle 2021).
  sources:
    - id: mirza2011
      authors: Mirza R, Koh TJ
      year: 2011
      title: "Dysregulation of monocyte/macrophage phenotype in wounds of diabetic mice"
      journal: Cytokine 56(2):256-264
      doi: 10.1016/j.cyto.2011.06.016
    - id: louiselle2021
      authors: Louiselle AE, Niemiec SM, Zgheib C, Liechty KW
      year: 2021
      title: "Macrophage polarization and diabetic wound healing"
      journal: Transl Res 236:109-116
      doi: 10.1016/j.trsl.2021.05.006
    - id: eming2014
      authors: Eming SA, Martin P, Tomic-Canic M
      year: 2014
      title: "Wound repair and regeneration: mechanisms, signaling, and translation"
      journal: Sci Transl Med 6(265):265sr6
      doi: 10.1126/scitranslmed.3009337

# ===========================================================================
# Biofilm module parameter validation
# ===========================================================================

biofilm_parameters:
  description: >
    Literature sources validating biofilm module parameters.
    Citations support colonization prevalence, growth dynamics,
    and inflammatory effects.
  sources:
    - id: james2008
      authors: James GA, Swogger E, Wolcott R, Pulcini ED, Secor P, Sestrich J, et al.
      year: 2008
      title: "Biofilms in chronic wounds"
      journal: Wound Repair Regen 16(1):37-44
      doi: 10.1111/j.1524-475X.2007.00321.x
      notes: >
        60% of chronic wounds contain biofilms vs 6% of acute wounds.
        Supports biofilm_enabled and biofilm_seed_delay parameters.
    - id: bjarnsholt2008
      authors: Bjarnsholt T, Kirketerp-Moller K, Jensen PO, Madsen KG, Phipps R, Krogfelt K, et al.
      year: 2008
      title: "Why chronic wounds will not heal: a novel hypothesis"
      journal: Wound Repair Regen 16(1):2-10
      doi: 10.1111/j.1524-475X.2007.00283.x
      notes: >
        Biofilm presence drives persistent inflammation via PAMPs;
        impairs neutrophil phagocytosis and macrophage function.
        Supports biofilm_inflammation_rate and biofilm_m1_block_threshold.
    - id: robson1997
      authors: Robson MC
      year: 1997
      title: "Wound infection: a failure of wound healing caused by an imbalance of bacteria"
      journal: Surg Clin North Am 77(3):637-650
      doi: 10.1016/S0039-6109(05)70572-7
      notes: >
        Foundational paper establishing 10^5 CFU/g as the critical bacterial
        load threshold for wound infection. Host-bacteria equilibrium model.
        Supports carrying_capacity normalization.

# ===========================================================================
# Angiogenesis module parameter validation
# ===========================================================================

angiogenesis_parameters:
  description: >
    Literature sources validating angiogenesis and VEGF module parameters.
  sources:
    - id: catrina2004
      authors: Catrina SB, Okamoto K, Pereira T, Brismar K, Poellinger L
      year: 2004
      title: "Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function"
      journal: Diabetes 53(12):3226-3232
      doi: 10.2337/diabetes.53.12.3226
      notes: >
        Hyperglycemia destabilizes HIF-1alpha, reducing VEGF transcription.
        Supports diabetic_vegf_factor=0.4 and hypoxia-driven VEGF production model.
    - id: thangarajah2009
      authors: Thangarajah H, Yao D, Chang EI, Shi Y, Jazayeri L, Vial IN, et al.
      year: 2009
      title: "The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues"
      journal: Proc Natl Acad Sci USA 106(32):13505-13510
      doi: 10.1073/pnas.0906670106
      notes: >
        Methylglyoxal modification of HIF-1alpha p300 binding domain reduces
        VEGF transcriptional response to hypoxia by ~60%.
        Supports vegf_factor=0.4 and vegf_hypoxia_threshold.
    - id: jetten2014
      authors: Jetten N, Verbruggen S, Gijbels MJ, Post MJ, De Winther MP, Donners MM
      year: 2014
      title: "Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo"
      journal: Angiogenesis 17(1):109-118
      doi: 10.1007/s10456-013-9381-6
      notes: >
        M2 macrophages are the primary VEGF source in wound angiogenesis.
        Supports M2-specific VEGF production (immune::ProduceVEGF) and
        the coupling between M1-to-M2 transition and vascular recovery.

# ===========================================================================
# Scar formation parameter validation
# Fibroblast lifecycle, TGF-beta kinetics, collagen deposition, scar-inflammation.
# ===========================================================================

scar_formation_parameters:
  description: >
    Literature sources validating fibroblast module and scar formation parameters.
    Complements myofibroblast_kinetics (timecourse) and collagen_deposition
    (accumulation curve) with sources for specific parameter choices.
  sources:
    # Fibroblast lifecycle timing (fibroblast_lifespan, _min_lifespan, _myofibroblast_delay)
    - id: desmouliere1995
      authors: Desmouliere A, Redard M, Darby I, Gabbiani G
      year: 1995
      title: "Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar"
      journal: Am J Pathol 146(1):56-66
      pmc: PMC1870783
      notes: >
        Myofibroblasts first appear day 4-6, peak day 10-15, apoptosis begins
        ~day 12, largely resolved by day 30. Supports fibroblast_min_lifespan=1680
        (7d) and fibroblast_lifespan=6720 (28d).
    - id: tomasek2002
      authors: Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA
      year: 2002
      title: "Myofibroblasts and mechano-regulation of connective tissue remodelling"
      journal: Nat Rev Mol Cell Biol 3(5):349-363
      doi: 10.1038/nrm809
      notes: >
        Two-stage model: fibroblast -> proto-myofibroblast (stress fibers) ->
        myofibroblast (alpha-SMA). Requires both TGF-beta1 and mechanical tension.
        Supports fibroblast_activation_threshold and _myofibroblast_threshold
        as sequential TGF-beta gates.

    # Myofibroblast differentiation timing (fibroblast_myofibroblast_delay)
    - id: vandewater2013
      authors: Van De Water L, Varney S, Tomasek JJ
      year: 2013
      title: "Mechanoregulation of the myofibroblast in wound contraction, scarring, and fibrosis: opportunities for new therapeutic intervention"
      journal: Adv Wound Care 2(4):122-141
      doi: 10.1089/wound.2012.0393
      notes: >
        In vitro differentiation to myofibroblast takes 3-5 days on rigid
        substrate with TGF-beta1. Supports fibroblast_myofibroblast_delay=480
        (48h = 2d in vivo with higher TGF-beta bioavailability).
    - id: hinz2007
      authors: Hinz B
      year: 2007
      title: "Formation and function of the myofibroblast during tissue repair"
      journal: J Invest Dermatol 127(3):526-537
      doi: 10.1038/sj.jid.5700613
      notes: >
        TGF-beta1 drives alpha-SMA expression; myofibroblasts generate 2x more
        contractile force than proto-myofibroblasts. Apoptosis triggered by
        loss of mechanical load and reduced TGF-beta. Supports
        fibroblast_apoptosis_threshold as low-TGF-beta trigger.

    # Mathematical model parameters (tgfb_diffusion, tgfb_decay, collagen_deposition_rate)
    - id: murphy2012
      authors: Murphy KE, Hall CL, Maini PK, McCue SW, McElwain DLS
      year: 2012
      title: "A fibrocontractive mechanochemical model of dermal wound closure incorporating realistic growth factor kinetics"
      journal: Bull Math Biol 74(5):1143-1170
      doi: 10.1007/s11538-011-9712-y
      notes: >
        Comprehensive parameter table for TGF-beta kinetics in wound closure:
        growth factor diffusion, decay, fibroblast chemotactic sensitivity,
        and collagen production rates. Supports order-of-magnitude calibration
        of tgfb_diffusion=0.03, tgfb_decay=0.005, collagen_deposition_rate=0.002.
    - id: dallon2001
      authors: Dallon JC, Sherratt JA, Maini PK
      year: 2001
      title: "Modeling the effects of transforming growth factor-beta on extracellular matrix alignment in dermal wound repair"
      journal: Wound Repair Regen 9(4):278-286
      doi: 10.1046/j.1524-475X.2001.00278.x
      notes: >
        TGF-beta modulates fibroblast speed and collagen alignment over 240h
        simulation window. Cell speed increases with TGF-beta concentration.
        Supports fibroblast_migration_speed scaling and chemotaxis model.

    # M2 macrophage TGF-beta production (m2_tgfb_rate)
    - id: koh2011
      authors: Koh TJ, DiPietro LA
      year: 2011
      title: "Inflammation and wound healing: the role of the macrophage"
      journal: Expert Rev Mol Med 13:e23
      doi: 10.1017/S1462399411001943
      notes: >
        M2 macrophages are the primary source of TGF-beta1 in wound
        granulation tissue. Transition from M1 to M2 phenotype initiates
        the fibroblast activation cascade. Supports m2_tgfb_rate parameter.

    # Scar-inflammation correlation (scar_accumulation_rate, scar_proportional_enabled)
    - id: ogawa2017
      authors: Ogawa R
      year: 2017
      title: "Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis"
      journal: Int J Mol Sci 18(3):606
      doi: 10.3390/ijms18030606
      notes: >
        Pathological scars are inflammatory disorders; scar severity reflects
        inflammation intensity, frequency, and duration. Supports
        scar_proportional_enabled model (scar = inflammation integral).
    - id: gauglitz2011
      authors: Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG
      year: 2011
      title: "Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies"
      journal: Mol Med 17(1-2):113-125
      doi: 10.2119/molmed.2009.00153
      notes: >
        Delayed epithelialization beyond 10-14 days dramatically increases
        hypertrophic scarring incidence. Prolonged inflammation is a primary
        driver. Supports inflammation-proportional scar model.

# ===========================================================================
# Tumor validation datasets
# Tumor model: cutaneous BCC/SCC, linear growth and proliferation kinetics.
# ===========================================================================

tumor_growth_rate:
  description: Linear growth rate of cutaneous BCC (diameter increase over months)
  consensus: consensus/tumor_growth_rate.csv
  raw_files:
    - raw/tumor_growth/fijalkowska2023_bcc_growth_meta.csv
    - raw/tumor_growth/sykes2020_superficial_bcc.csv
    - raw/tumor_growth/kricker2014_community_bcc.csv
  columns: [month, diameter_mm]
  units: {month: months, diameter_mm: millimeters}
  normalization: absolute (mm from initial ~4mm diameter)
  notes: >
    BCC mean linear growth rate 0.71 mm/month (Fijalkowska 2023 meta-analysis).
    Superficial BCC grows ~0.81 mm2/month surface area (Sykes 2020).
    Starting diameter 4mm matches simulation tumor_diameter parameter.
  sources:
    - id: fijalkowska2023
      authors: Fijalkowska M, Bonczar M, Jastrzebski I, Ostrowski P, Antoszewski B, Koziej M
      year: 2023
      title: "Growth rate of basal cell carcinoma: a meta-analysis and systematic review"
      journal: Postepy Dermatol Alergol 40(2):220-224
      doi: 10.5114/ada.2023.124795
    - id: sykes2020
      authors: Sykes AJ, Weedon D, Raasch BA
      year: 2020
      title: "Growth rate of clinically diagnosed superficial basal cell carcinoma and changes in dermoscopic features over time"
      journal: Australas J Dermatol 61(4):330-335
      doi: 10.1111/ajd.13352
    - id: kricker2014
      authors: Kricker A, Armstrong BK, Hansen V, Watson A, Singh-Khaira G, Lecathelinais C, et al.
      year: 2014
      title: "Basal cell carcinoma and squamous cell carcinoma growth rates and determinants of size in community patients"
      journal: J Am Acad Dermatol 70(5):880-887
      doi: 10.1016/j.jaad.2013.11.009

tumor_doubling_time:
  description: Volume doubling time for cutaneous BCC and SCC
  consensus: consensus/tumor_doubling_time.csv
  raw_files:
    - raw/tumor_doubling/al_qahtani2020_bcc_doubling.csv
    - raw/tumor_doubling/tejera2023_skin_cancer_tdt.csv
  columns: [tumor_type, doubling_time_days]
  units: {doubling_time_days: days}
  normalization: absolute (days per volume doubling)
  notes: >
    BCC volume doubling time ~148 days mean (Khoo 2019).
    SCC doubling times much shorter: 16-35 days for aggressive cases (Tejera 2023).
    Simulation doubling time depends on tumor_cycle_factor and tumor_growth_rate.
  sources:
    - id: khoo2019
      authors: Khoo ABS, Goon PKY, Sudhoff H, Goon PKC
      year: 2019
      title: "Comparative analyses of tumour volume doubling times for periocular and non-periocular head and neck basal cell carcinomas"
      journal: Acta Derm Venereol 99(13):1266-1269
      doi: 10.2340/00015555-3325
    - id: tejera2023
      authors: Tejera-Vaquerizo A, Canueto J, Nagore E, et al.
      year: 2023
      title: "Tumor doubling time in skin cancer: can it be estimated and is it useful?"
      journal: Actas Dermosifiliogr 114(4):T313-T321
      doi: 10.1016/j.ad.2022.10.034

tumor_proliferation_index:
  description: Ki-67 proliferation index for cutaneous BCC and SCC by subtype/grade
  consensus: consensus/tumor_proliferation_index.csv
  raw_files:
    - raw/tumor_proliferation/toth2012_bcc_ki67.csv
    - raw/tumor_proliferation/alferraly2019_scc_ki67.csv
    - raw/tumor_proliferation/alsader1996_bcc_scc_indices.csv
  columns: [tumor_type, ki67_pct]
  units: {ki67_pct: percent of cells Ki-67 positive}
  normalization: absolute (percentage)
  notes: >
    Ki-67 marks cells in S/G2/M phases. BCC mean 27.4% (Toth 2012), range 2-70%.
    SCC higher: 22-68% depending on grade (Kurnia 2020).
    Simulation equivalent: fraction of tumor cells in S+G2+M phases.
  sources:
    - id: toth2012
      authors: Toth DP, Bognar G, Gurbity-Palfi T, Vizkeleti L, Dobozy A, Kemeny L
      year: 2012
      title: "Immunohistochemical evaluation of proliferative activity (Ki-67 index) in different histological types of cutaneous basal cell carcinoma"
      journal: Biologia 67(3):610-616
      doi: 10.2478/s11756-012-0035-8
    - id: alferraly2019
      authors: Alferraly IT, Munir D, Putra IB, Sembiring RJ
      year: 2019
      title: "Correlation of Ki-67 expression as tumor cell proliferation activity marker with cutaneous squamous cell carcinoma grading"
      journal: Open Access Maced J Med Sci 7(20):3384-3386
      doi: 10.3889/oamjms.2019.428
    - id: alsader1996
      authors: al-Sader MH, Doyle E, Kay EW, Bennett M, Walsh CB, Curran B, Leader M
      year: 1996
      title: "Proliferation indexes - a comparison between cutaneous basal and squamous cell carcinomas"
      journal: J Clin Pathol 49(7):549-551
      doi: 10.1136/jcp.49.7.549

# ===========================================================================
# Core tissue parameter validation
# Oxygen, water, calcium, KGF, cell cycle, migration, mechanics.
# ===========================================================================

core_tissue_parameters:
  description: >
    Literature sources validating core bdm.toml parameters for epidermis
    and dermis continuum fields, cell cycle, division mechanics, and migration.
  sources:
    # Oxygen diffusion and consumption
    - id: schugart2008
      authors: Schugart RC, Friedman A, Zhao R, Sen CK
      year: 2008
      title: "Wound angiogenesis as a function of tissue oxygen tension: a mathematical model"
      journal: Proc Natl Acad Sci USA 105(7):2628-2633
      doi: 10.1073/pnas.0711642105
      notes: >
        Mathematical wound angiogenesis model with O2 diffusion, capillary
        density, and VEGF coupling. Supports oxygen_diffusion and VEGF
        hypoxia threshold parameters.
    - id: stucker2002
      authors: Stucker M, Struk A, Altmeyer P, Herde M, Baumgartl H, Lubbers DW
      year: 2002
      title: "The cutaneous uptake of atmospheric oxygen contributes significantly to the oxygen supply of human dermis and epidermis"
      journal: J Physiol 538(Pt 3):985-994
      doi: 10.1113/jphysiol.2001.013067
      notes: >
        In vivo transcutaneous pO2 measurements in human skin. Supports
        oxygen_decay parameter magnitude for epidermal O2 consumption.

    # KGF growth factor
    - id: rubin1989
      authors: Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA
      year: 1989
      title: "Purification and characterization of a newly identified growth factor specific for epithelial cells"
      journal: Proc Natl Acad Sci USA 86(3):802-806
      doi: 10.1073/pnas.86.3.802
      notes: >
        Original KGF characterization. Half-maximal stimulation data
        supports kgf_half_maximal Michaelis-Menten parameter.
    - id: werner1992
      authors: Werner S, Peters KG, Longaker MT, Fuller-Pace F, Banda MJ, Williams LT
      year: 1992
      title: "Large induction of keratinocyte growth factor expression in the dermis during wound healing"
      journal: Proc Natl Acad Sci USA 89(15):6896-6900
      doi: 10.1073/pnas.89.15.6896
      notes: >
        KGF expressed exclusively by dermal fibroblasts, 160-fold upregulation
        post-wounding. Supports paracrine continuum source model and
        kgf_decay_length parameter.

    # Water / TEWL
    - id: schwindt1998
      authors: Schwindt DA, Wilhelm KP, Maibach HI
      year: 1998
      title: "Water diffusion characteristics of human stratum corneum at different anatomical sites in vivo"
      journal: J Invest Dermatol 111(3):385-389
      doi: 10.1046/j.1523-1747.1998.00321.x
      notes: >
        Measured water diffusion through stratum corneum in vivo.
        Supports water_diffusion parameter.
    - id: pinnagoda1990
      authors: Pinnagoda J, Tupker RA, Agner T, Serup J
      year: 1990
      title: "Guidelines for transepidermal water loss (TEWL) measurement"
      journal: Contact Dermatitis 22(3):164-178
      doi: 10.1111/j.1600-0536.1990.tb01553.x
      notes: >
        Standardized TEWL measurement protocol. Normal TEWL 5-10 g/m2/h.
        Supports water_decay and water_surface_loss_rate parameters.

    # Calcium gradient
    - id: grabe2005
      authors: Grabe N, Neuber K
      year: 2005
      title: "A multicellular systems biology model predicts epidermal morphology, kinetics and Ca2+ flow"
      journal: Bioinformatics 21(17):3541-3547
      doi: 10.1093/bioinformatics/bti585
      notes: >
        Agent-based epidermal model with Ca2+ flow. Predicted calcium
        profile matches physiological measurements. Foundational paper
        for calcium sigmoid profile parameters.
    - id: menon1985
      authors: Menon GK, Grayson S, Elias PM
      year: 1985
      title: "Ionic calcium reservoirs in mammalian epidermis: ultrastructural localization by ion-capture cytochemistry"
      journal: J Invest Dermatol 84(6):508-512
      doi: 10.1111/1523-1747.ep12273485
      notes: >
        Ca2+ low in basale, increases through spinosum, peaks in granulosum.
        Supports calcium_basal and calcium_peak parameters.
    - id: bikle2012
      authors: Bikle DD, Xie Z, Tu CL
      year: 2012
      title: "Calcium regulation of keratinocyte differentiation"
      journal: Expert Rev Endocrinol Metab 7(4):461-472
      doi: 10.1586/eem.12.34
      notes: >
        >0.1 mM Ca2+ triggers calcium switch initiating differentiation.
        Supports ca_spinous_threshold=0.1 as differentiation gate.
    - id: adams2015
      authors: Adams MP, Mallet DG, Pettet GJ
      year: 2015
      title: "Towards a quantitative theory of epidermal calcium profile formation in unwounded skin"
      journal: PLoS ONE 10(1):e0116751
      doi: 10.1371/journal.pone.0116751
      notes: >
        Mathematical model of epidermal calcium profile. Quantitative fit
        to measured gradient. Supports calcium sigmoid parameters.

    # Cell cycle
    - id: adra2010
      authors: Adra S, Sun T, MacNeil S, Holcombe M, Smallwood R
      year: 2010
      title: "Development of a three dimensional multiscale computational model of the human epidermis"
      journal: PLoS ONE 5(1):e8511
      doi: 10.1371/journal.pone.0008511
      notes: >
        Agent-based epidermal model with 15-24h cell cycle for actively
        cycling cells and 10um cell diameter. Supports cell cycle and
        division_diameter parameters.

    # Division mechanics
    - id: jones1993
      authors: Jones PH, Watt FM
      year: 1993
      title: "Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression"
      journal: Cell 73(4):713-724
      doi: 10.1016/0092-8674(93)90251-K
      notes: >
        TA cells undergo 1-5 rounds of division before terminal differentiation.
        Foundational paper for max_ta_divisions=4.
    - id: clayton2007
      authors: Clayton E, Doupe DP, Klein AM, Winton DJ, Simons BD, Jones PH
      year: 2007
      title: "A single type of progenitor cell maintains normal epidermis"
      journal: Nature 446(7132):185-189
      doi: 10.1038/nature05574
      notes: >
        ~80% asymmetric divisions at homeostasis. Supports p_asymmetric=0.7.
    - id: barrandon1985
      authors: Barrandon Y, Green H
      year: 1985
      title: "Cell size as a determinant of the clone-forming ability of human keratinocytes"
      journal: Proc Natl Acad Sci USA 82(16):5390-5394
      doi: 10.1073/pnas.82.16.5390
      notes: >
        Clone-forming keratinocytes <=11um, committed >=12um. Smallest
        basal stem cells ~9um. Supports division_diameter parameter.
    - id: sun2007
      authors: Sun T, McMinn P, Coakley S, Holcombe M, Smallwood R, MacNeil S
      year: 2007
      title: "An integrated systems biology approach to understanding the rules of keratinocyte colony formation"
      journal: J R Soc Interface 4(17):1077-1117
      doi: 10.1098/rsif.2007.0227
      notes: >
        Contact inhibition by neighbor count; packing geometry threshold.
        Supports max_neighbors=14 (sphere packing ~12-14).
    - id: li1998
      authors: Li A, Simmons PJ, Kaur P
      year: 1998
      title: "Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype"
      journal: Proc Natl Acad Sci USA 95(7):3902-3907
      doi: 10.1073/pnas.95.7.3902
      notes: >
        Alpha6-bright/CD71-dim stem fraction ~5% of basal cells in vivo.
        Model stem_fraction=0.50 represents full proliferative fraction
        (stem + TA cells).

    # Cell mechanics
    - id: lulevich2010
      authors: Lulevich V, Zink T, Chen HY, Liu FT, Liu GY
      year: 2010
      title: "Single cell mechanics of keratinocyte cells"
      journal: Ultramicroscopy 110(12):1435-1442
      doi: 10.1016/j.ultramic.2010.07.009
      notes: >
        AFM-based single cell compression. Keratinocyte Young's modulus
        1-10 kPa for Hertz contact model. Supports repulsion_coeff.

    # Migration
    - id: safferling2013
      authors: Safferling K, Sutterlin T, Westphal K, Ernst C, Breuhahn K, et al.
      year: 2013
      title: "Wound healing revised: a novel reepithelialization mechanism revealed by in vitro and in silico models"
      journal: J Cell Biol 203(4):691-709
      doi: 10.1083/jcb.201212020
      notes: >
        Wound edge advancement 20-60 um/h. Supports migration_speed.
    - id: mcdougall2006
      authors: McDougall S, Dallon J, Sherratt J, Maini P
      year: 2006
      title: "Fibroblast migration and collagen deposition during dermal wound healing"
      journal: Philos Trans R Soc A 364(1843):1385-1405
      doi: 10.1098/rsta.2006.1773
      notes: >
        Fibroblast migration 10-30 um/h in wound bed. Supports
        fibroblast migration_speed parameter.
    - id: lammermann2008
      authors: Lammermann T, Bader BL, Monkley SJ, et al.
      year: 2008
      title: "Rapid leukocyte migration by integrin-independent flowing and squeezing"
      journal: Nature 453(7191):51-55
      doi: 10.1038/nature06887
      notes: >
        Leukocyte 3D migration up to 20-30 um/min for neutrophils.
        Macrophages ~1-4 um/min. Supports immune migration_speed.

    # Desquamation
    - id: iizuka1994
      authors: Iizuka H
      year: 1994
      title: "Epidermal turnover time"
      journal: J Dermatol Sci 8(3):215-217
      doi: 10.1016/0923-1811(94)90057-4
      notes: >
        Total epidermal turnover 47-48 days. Stratum corneum transit ~14 days.

# ===========================================================================
# Inflammation and immune parameter validation
# Cytokine diffusion, decay, efferocytosis, chemotaxis.
# ===========================================================================

inflammation_parameters:
  description: >
    Literature sources validating inflammation module parameters for
    cytokine diffusion, decay, and pro/anti-inflammatory balance.
  sources:
    - id: oyler_yaniv2017
      authors: Oyler-Yaniv A, Oyler-Yaniv J, Whitlock BM, et al.
      year: 2017
      title: "A tunable diffusion-consumption mechanism of cytokine propagation enables plasticity in cell-to-cell communication"
      journal: Immunity 46(4):609-620
      doi: 10.1016/j.immuni.2017.03.011
      notes: >
        Cytokine diffusion in dense tissue ~10^-7 to 10^-8 cm^2/s.
        Supports inflammation diffusion parameter.
    - id: bemelmans1996
      authors: Bemelmans MH, van Tits LJ, Buurman WA
      year: 1996
      title: "Tumor necrosis factor: function, release and clearance"
      journal: Crit Rev Immunol 16(1):1-11
      doi: 10.1615/CritRevImmunol.v16.i1.10
      notes: >
        TNF-alpha serum half-life 14-18 minutes. Supports
        inflammation decay parameter.
    - id: mosser2008
      authors: Mosser DM, Zhang X
      year: 2008
      title: "Interleukin-10: new perspectives on an old cytokine"
      journal: Immunol Rev 226:205-218
      doi: 10.1111/j.1600-065X.2008.00706.x
      notes: >
        IL-10 inhibits TNF-alpha and IL-1beta production. Supports
        split pro/anti-inflammatory field model.
    - id: huhn1996
      authors: Huhn RD, Radwanski E, O'Connell SM, Sturgill MG, Clarke L, Cody RP, Affrime MB, Cutler DL
      year: 1996
      title: "Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers"
      journal: Blood 87(2):699-705
      doi: 10.1182/blood.V87.2.699.bloodjournal872699
      notes: >
        IL-10 terminal half-life 2.3-3.7h in healthy volunteers.
        Supports anti_decay=0.002 parameter for anti-inflammatory field.
    - id: werner2003
      authors: Werner S, Grose R
      year: 2003
      title: "Regulation of wound healing by growth factors and cytokines"
      journal: Physiol Rev 83(3):835-870
      doi: 10.1152/physrev.00031.2002
      notes: >
        DAMPs and IL-1alpha release from damaged keratinocytes sustain
        inflammation proportional to open wound area. Supports
        wound_source_rate parameter for continuum inflammation source.
    - id: ravichandran2010
      authors: Ravichandran KS
      year: 2010
      title: "Find-me and eat-me signals in apoptotic cell clearance"
      journal: J Exp Med 207(9):1807-1817
      doi: 10.1084/jem.20101157
      notes: >
        Find-me signals create short-range chemotactic gradient.
        Effective range tens to ~200 um. Supports efferocytosis_radius.
    - id: savill1989
      authors: Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C
      year: 1989
      title: "Macrophage phagocytosis of aging neutrophils in inflammation"
      journal: J Clin Invest 83(3):865-875
      doi: 10.1172/JCI113970
      notes: >
        Macrophages preferentially recognize aging/apoptotic neutrophils
        expressing phosphatidylserine. Supports efferocytosis_age_fraction.

# ===========================================================================
# Dermis tissue integrity parameter validation
# ===========================================================================

dermis_parameters:
  description: >
    Literature sources for dermal tissue integrity, ECM structure, and
    wound bed remodeling kinetics.
  sources:
    - id: clark1996
      authors: Clark RAF
      year: 1996
      title: "The Molecular and Cellular Biology of Wound Repair"
      journal: Springer
      doi: 10.1007/978-1-4899-0185-9
      notes: >
        Comprehensive reference for dermal wound healing phases.
        Papillary dermis (loose connective tissue) recovers faster than
        reticular dermis (dense collagen). Supports per-layer rate factors.
    - id: schultz2009
      authors: Schultz GS, Wysocki A
      year: 2009
      title: "Interactions between extracellular matrix and growth factors in wound healing"
      journal: Wound Repair Regen 17(2):153-162
      doi: 10.1111/j.1524-475X.2009.00466.x
      notes: >
        MMP-mediated ECM degradation in chronic wounds. Supports
        dermis_mmp_degradation parameter.

# ===========================================================================
# Perfusion and angiogenesis parameter validation
# ===========================================================================

perfusion_parameters:
  description: >
    Literature sources validating perfusion and angiogenesis module parameters.
  sources:
    - id: braverman2000
      authors: Braverman IM
      year: 2000
      title: "The cutaneous microcirculation"
      journal: J Investig Dermatol Symp Proc 5(1):3-9
      doi: 10.1046/j.1087-0024.2000.00010.x
      notes: >
        Papillary dermis capillary density 2x reticular; hypodermis lowest.
        Supports per-layer perfusion profiles (papillary=1.0, reticular=0.6, hypodermis=0.3).
    - id: singer1999
      authors: Singer AJ, Clark RAF
      year: 1999
      title: "Cutaneous wound healing"
      journal: N Engl J Med 341(10):738-746
      doi: 10.1056/NEJM199909023411006
      notes: >
        Capillary buds begin 24-48h post-wounding; circulation established
        by 72h. Supports angio_delay=240 steps (~24h).
    - id: johnson2014
      authors: Johnson KE, Wilgus TA
      year: 2014
      title: "Vascular endothelial growth factor and angiogenesis in the regulation of cutaneous wound repair"
      journal: Adv Wound Care 3(10):647-661
      doi: 10.1089/wound.2013.0517
      notes: >
        VEGF levels elevated days 3-5, normalize days 7-14. Vessel density
        near-normal by days 14-21. Supports VEGF production and consumption rates.
    - id: flegg2012
      authors: Flegg JA, Byrne HM, Flegg MB, McElwain DLS
      year: 2012
      title: "Wound healing angiogenesis: the clinical implications of a simple mathematical model"
      journal: J Theor Biol 300:309-316
      doi: 10.1016/j.jtbi.2012.01.043
      notes: >
        PDE model for O2 supply via diffusion and new vessel formation.
        Supports angio_vegf_rate parameter calibration.
    - id: jesaitis2003
      authors: Jesaitis AJ, Franklin MJ, Berglund D, Sasaki M, Lord CI, Bleazard JB, et al.
      year: 2003
      title: "Compromised host defense on Pseudomonas aeruginosa biofilms"
      journal: J Immunol 171(8):4329-4339
      doi: 10.4049/jimmunol.171.8.4329
      notes: >
        Biofilm bacteria induce frustrated phagocytosis in neutrophils.
        Supports neutrophil_clearance rate for biofilm module.
    - id: gibson2018
      authors: Gibson B, Wilson DJ, Feil E, Eyre-Walker A
      year: 2018
      title: "The distribution of bacterial doubling times in the wild"
      journal: Proc R Soc B 285(1880):20180789
      doi: 10.1098/rspb.2018.0789
      notes: >
        S. aureus in vivo doubling time 1.8h; P. aeruginosa 1.9-2.4h.
        Supports biofilm growth_rate parameter (~2h doubling).
    - id: davis2008
      authors: Davis SC, Ricotti C, Cazzaniga A, Welsh E, Eaglstein WH, Mertz PM
      year: 2008
      title: "Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo"
      journal: Wound Repair Regen 16(1):23-29
      doi: 10.1111/j.1524-475X.2007.00303.x
      notes: >
        Biofilm-like structures observed 48h post-inoculation in porcine
        wound model. Supports biofilm seed_delay=480 (~48h).

mmp_ecm_remodeling:
  description: MMP/TIMP dynamics and ECM degradation in wound healing
  sources:
    - id: lobmann2002
      authors: Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H
      year: 2002
      title: "Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients"
      journal: Diabetologia 45:1011-1016
      doi: 10.1007/s00125-002-0868-8
      notes: >
        MMP-1 elevated 65-fold and MMP-9 14-fold in diabetic vs acute wounds.
        TIMP-2 reduced 2-fold. Supports diabetic_mmp_factor=3.0 and
        diabetic_timp_factor=0.5 parameters.
    - id: nagase1999
      authors: Nagase H, Woessner JF
      year: 1999
      title: "Matrix metalloproteinases"
      journal: J Biol Chem 274(31):21491-21494
      doi: 10.1074/jbc.274.31.21491
      notes: >
        Review of MMP family biochemistry. MMP-1 (fibroblast collagenase),
        MMP-9 (gelatinase B from macrophages/neutrophils). Supports
        mmp_diffusion and fibroblast MMP production parameters.
    - id: ladwig2002
      authors: Ladwig GP, Robson MC, Liu R, Kuhn MA, Muir DF, Schultz GS
      year: 2002
      title: "Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers"
      journal: Wound Repair Regen 10(1):26-37
      doi: 10.1046/j.1524-475x.2002.10903.x
      notes: >
        High MMP-9:TIMP-1 ratio inversely correlates with healing.
        Supports MMP-collagen degradation rate calibration.

fibronectin_provisional_matrix:
  description: Fibronectin dynamics as provisional wound matrix scaffold
  sources:
    - id: clark1990
      authors: Clark RAF
      year: 1990
      title: "Fibronectin matrix deposition and fibronectin receptor expression in healing and normal skin"
      journal: J Invest Dermatol 94(6 Suppl):128S-134S
      doi: 10.1111/1523-1747.ep12876104
      notes: >
        Plasma fibronectin provides initial wound matrix; cellular fibronectin
        deposited by fibroblasts replaces it. Supports fibronectin_serum_rate
        and fibronectin_deposition_rate parameters.
    - id: grinnell1984
      authors: Grinnell F
      year: 1984
      title: "Fibronectin and wound healing"
      journal: J Cell Biochem 26(2):107-116
      doi: 10.1002/jcb.240260206
      notes: >
        Fibronectin promotes keratinocyte migration via integrin alpha5-beta1.
        Supports fibronectin_migration_boost parameter.
    - id: hynes1990
      authors: Hynes RO
      year: 1990
      title: "Fibronectins"
      journal: Springer Series in Molecular Biology
      doi: 10.1007/978-1-4612-3264-3
      notes: >
        Comprehensive monograph on fibronectin structure, function, and
        role in cell adhesion and wound healing. General reference for
        fibronectin module parameters.

# ===========================================================================
# Normal skin profile literature
# References for profiles/normal.toml baseline parameters.
# ===========================================================================

normal_skin_profile:
  description: >
    Literature sources for baseline normal skin parameters: cell cycle
    kinetics, stem/TA cell hierarchy, calcium-driven differentiation,
    and paracrine growth factor signaling.
  sources:
    - id: dover1988
      authors: Dover R, Potten CS
      year: 1988
      title: "Heterogeneity and cell cycle analyses from time-lapse studies of human keratinocytes in vitro"
      journal: J Cell Sci 89(3):359-371
      doi: 10.1242/jcs.89.3.359
      notes: >
        Time-lapse cell cycle analysis of human keratinocytes. Mean cycle
        time ~17h with heterogeneity. Supports g1_duration=7.0, s_duration=6.0,
        g2_duration=3.0, m_duration=1.0 parameters.
    - id: potten1988
      authors: Potten CS, Morris RJ
      year: 1988
      title: "Epithelial stem cells in vivo"
      journal: J Cell Sci Suppl 10:45-62
      doi: 10.1242/jcs.1988.supplement_10.4
      notes: >
        Epidermal proliferative unit model: stem cells with unlimited
        self-renewal, TA cells with 3-5 divisions before terminal
        differentiation. Supports max_ta_divisions=4, p_asymmetric=0.7.
    - id: bikle2012
      authors: Bikle DD, Xie Z, Tu CL
      year: 2012
      title: "Calcium regulation of keratinocyte differentiation"
      journal: Expert Rev Endocrinol Metab 7(4):461-472
      doi: 10.1586/eem.12.34
      notes: >
        Calcium gradient from low (basal) to peak (granulosum) drives
        sequential keratinocyte differentiation via CaR signaling.
        Supports calcium_basal=0.05, calcium_peak=1.5 and differentiation
        threshold parameters.
    - id: finch2004
      authors: Finch PW, Rubin JS
      year: 2004
      title: "Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair"
      journal: Adv Cancer Res 91:69-136
      doi: 10.1016/S0065-230X(04)91003-2
      notes: >
        KGF (FGF-7) is a paracrine factor from mesenchymal cells that
        drives epithelial proliferation and repair. Supports kgf_basal_conc
        and kgf_max_boost parameters.

# ===========================================================================
# Aged skin profile literature
# References for profiles/aged.toml parameter overrides.
# ===========================================================================

aged_skin_profile:
  description: >
    Literature sources for aged skin profile parameters. Aged skin shows
    slower epidermal turnover, thinner stratum corneum, and reduced dermal
    vasculature compared to young adult skin.
  sources:
    - id: gilchrest1983
      authors: Gilchrest BA
      year: 1983
      title: "In vitro assessment of keratinocyte aging"
      journal: J Invest Dermatol 81(1 Suppl):184s-189s
      doi: 10.1111/1523-1747.ep12541084
      notes: >
        Aged keratinocytes proliferate more slowly in vitro with reduced
        mitogenic responsiveness. Supports g1_duration=9.0 and s_duration=8.0
        (total cycle ~20h vs ~17h in young adult).
    - id: farage2013
      authors: Farage MA, Miller KW, Elsner P, Maibach HI
      year: 2013
      title: "Characteristics of the aging skin"
      journal: Adv Wound Care 2(1):5-10
      doi: 10.1089/wound.2011.0356
      notes: >
        Review of age-related skin changes: thinner stratum corneum,
        reduced barrier function, slower transepidermal water loss recovery.
        Supports volume_z_cornified=20.0, water_recovery_rate=0.03, and
        basal perfusion=0.8 parameters.
    - id: sgonc2013
      authors: Sgonc R, Gruber J
      year: 2013
      title: "Age-related aspects of cutaneous wound healing: a mini-review"
      journal: Gerontology 59(2):159-164
      doi: 10.1159/000342344
      notes: >
        Fewer active stem cells, reduced growth factor responsiveness,
        and delayed inflammatory resolution in aged skin. Supports
        stem_fraction=0.30 parameter.

# ===========================================================================
# Treatment intervention literature
# References for the 8 therapeutic interventions modeled in treatments/.
# ===========================================================================

treatment_interventions:
  description: >
    Literature sources supporting treatment parameter choices for diabetic
    wound interventions. Each treatment overlay modifies diabetic dysfunction
    parameters proportional to published clinical/preclinical effect sizes.
  sources:
    # Anti-inflammatory (anti-TNF-alpha)
    - id: goren2007
      authors: Goren I, Muller E, Schiefelbein D, Christen U, Pfeilschifter J, Muhl H, Frank S
      year: 2007
      title: "Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages"
      journal: J Invest Dermatol 127(9):2259-2267
      doi: 10.1038/sj.jid.5700842
      notes: >
        Anti-TNF-alpha restores wound healing in diabetic ob/ob mice via
        macrophage inactivation. Supports anti_inflammatory treatment
        m1_duration_factor and resolution_factor adjustments.
    - id: ashcroft2012
      authors: Ashcroft GS, Jeong MJ, Ashworth JJ, Hardman M, Jin W, Moutsopoulos N, et al.
      year: 2012
      title: "Tumor necrosis factor-alpha (TNF-alpha) is a therapeutic target for impaired cutaneous wound healing"
      journal: Wound Repair Regen 20(1):38-49
      doi: 10.1111/j.1524-475X.2011.00748.x
      notes: >
        Topical anti-TNF-alpha neutralizing antibodies blunt leukocyte
        recruitment, shift M1/M2 balance, and accelerate wound closure.
    - id: siqueira2010
      authors: Siqueira MF, Li J, Chehab L, Desta T, Chino T, Krothpali N, et al.
      year: 2010
      title: "Impaired wound healing in mouse models of diabetes is mediated by TNF-alpha dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1)"
      journal: Diabetologia 53(2):378-388
      doi: 10.1007/s00125-009-1529-y
      notes: >
        TNF-alpha dysregulation drives fibroblast apoptosis and reduced
        proliferation via FOXO1 pathway in diabetic wounds.

    # Hyperbaric oxygen therapy (HBO)
    - id: londahl2010
      authors: Londahl M, Katzman P, Nilsson A, Hammarlund C
      year: 2010
      title: "Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes"
      journal: Diabetes Care 33(5):998-1003
      doi: 10.2337/dc09-1754
      notes: >
        HODFU RCT: HBO significantly improved complete healing of chronic
        DFUs at 1 year. Supports HBO treatment perfusion and VEGF adjustments.
    - id: fedorko2016
      authors: Fedorko L, Bowen JM, Jones W, Englesbe G, Englesbe J, Dain S, et al.
      year: 2016
      title: "Hyperbaric oxygen therapy does not reduce indications for amputation in patients with diabetes with nonhealing ulcers of the lower limb"
      journal: Diabetes Care 39(3):392-399
      doi: 10.2337/dc15-2001
      notes: >
        Negative RCT: no significant healing difference with HBO. Provides
        important context that HBO effect sizes are debated.

    # Negative pressure wound therapy (NPWT)
    - id: morykwas1997
      authors: Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W
      year: 1997
      title: "Vacuum-assisted closure: a new method for wound control and treatment"
      journal: Ann Plast Surg 38(6):553-562
      doi: 10.1097/00000637-199706000-00001
      notes: >
        Original NPWT description. 4x blood flow increase at -125 mmHg.
        Granulation tissue formation accelerated. Supports NPWT perfusion
        and proliferation parameter adjustments.
    - id: armstrong2005
      authors: Armstrong DG, Lavery LA
      year: 2005
      title: "Negative pressure wound therapy after partial diabetic foot amputation"
      journal: Lancet 366(9498):1704-1710
      doi: 10.1016/S0140-6736(05)67695-7
      notes: >
        RCT: NPWT improved healing rate (56% vs 39%) in diabetic foot
        amputations. Supports NPWT treatment parameter magnitudes.

    # Doxycycline (sub-antimicrobial MMP inhibitor)
    - id: smith1999
      authors: Smith GN Jr, Mickler EA, Hasty KA, Brandt KD
      year: 1999
      title: "Specificity of inhibition of matrix metalloproteinase activity by doxycycline"
      journal: Arthritis Rheum 42(6):1140-1146
      doi: 10.1002/1529-0131(199906)42:6<1140::AID-ANR10>3.0.CO;2-7
      notes: >
        Sub-antimicrobial doxycycline inhibits MMP-1, -8, -9, -13.
        IC50 values support mmp_factor adjustment from 3.0 to 1.5.

    # Growth factor (PDGF-BB / becaplermin)
    - id: steed2006
      authors: Steed DL
      year: 2006
      title: "Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers"
      journal: Plast Reconstr Surg 117(7 Suppl):143S-149S
      doi: 10.1097/01.prs.0000222526.21512.4c
      notes: >
        Becaplermin (rhPDGF-BB) improved complete healing in DFU clinical
        trials. Supports growth_factor treatment fibroblast activation
        and density parameters.
    - id: smiell1998
      authors: Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH
      year: 1998
      title: "Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers"
      journal: Wound Repair Regen 7(5):335-346
      doi: 10.1046/j.1524-475X.1999.00335.x
      notes: >
        FDA pivotal trial data for becaplermin. 50% improvement in
        complete healing vs. placebo.

    # MSC therapy
    - id: cao2017
      authors: Cao Y, Gang X, Sun C, Wang G
      year: 2017
      title: "Mesenchymal stem cells improve healing of diabetic foot ulcer"
      journal: J Diabetes Res 2017:9328347
      doi: 10.1155/2017/9328347
      notes: >
        Review of MSC mechanisms in DFU: paracrine factors (VEGF, PDGF,
        TGF-beta, IL-10) modulate all four dysfunction axes.

    # Moisture dressings
    - id: winter1962
      authors: Winter GD
      year: 1962
      title: "Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig"
      journal: Nature 193:293-294
      doi: 10.1038/193293a0
      notes: >
        Foundational moist wound healing study. Epithelialization 2x faster
        under occlusive dressing vs. air-exposed. Supports moisture treatment
        water_recovery_rate and surface_loss_rate adjustments.
    - id: junker2013
      authors: Junker JPE, Kamel RA, Caterson EJ, Eriksson E
      year: 2013
      title: "Clinical impact upon wound healing and inflammation in moist, wet, and dry environments"
      journal: Adv Wound Care 2(7):348-356
      doi: 10.1089/wound.2012.0412
      notes: >
        Moist environment reduces inflammation, improves keratinocyte
        migration, and accelerates wound closure. Supports moisture
        treatment inflammation_decay adjustment.

# ===========================================================================
# Hyaluronan module parameter validation
# ===========================================================================

hyaluronan_parameters:
  description: >
    Literature sources for hyaluronan (HA) dynamics in wound healing:
    synthesis, degradation, migration scaffold, and water retention.
  sources:
    - id: toole2004
      authors: Toole BP
      year: 2004
      title: "Hyaluronan: from extracellular glue to pericellular cue"
      journal: Nat Rev Cancer 4(7):528-539
      doi: 10.1038/nrc1391
      notes: >
        HA as pericellular coat and migration scaffold. CD44-mediated
        signaling drives keratinocyte and fibroblast motility. General
        reference for hyaluronan module.
    - id: stern2006
      authors: Stern R, Asari AA, Sugahara KN
      year: 2006
      title: "Hyaluronan fragments: an information-rich system"
      journal: Eur J Cell Biol 85(8):699-715
      doi: 10.1016/j.ejcb.2006.05.009
      notes: >
        HA fragment size determines signaling: high-MW HA is anti-inflammatory,
        low-MW fragments (via hyaluronidase) are pro-inflammatory and
        pro-angiogenic. Supports ha_decay parameter.
    - id: aya2014
      authors: Aya KL, Stern R
      year: 2014
      title: "Hyaluronan in wound healing: rediscovering a major player"
      journal: Wound Repair Regen 22(5):579-593
      doi: 10.1111/wrr.12214
      notes: >
        Review of HA roles across all wound phases. CD44-mediated keratinocyte
        migration, HA-rich provisional matrix, MW-dependent immune modulation.
    - id: chen1999
      authors: Chen WY, Abatangelo G
      year: 1999
      title: "Functions of hyaluronan in wound repair"
      journal: Wound Repair Regen 7(2):79-89
      doi: 10.1046/j.1524-475x.1999.00079.x
      notes: >
        HA as provisional matrix scaffold for cell migration and proliferation.
        Covers synthesis/degradation kinetics and the transition from HA-rich
        granulation tissue to collagen-rich scar.

# ===========================================================================
# Elastin module parameter validation
# ===========================================================================

elastin_parameters:
  description: >
    Literature sources for elastic fiber network dynamics: tropoelastin
    deposition, lysyl oxidase cross-linking, and wound recovery.
  sources:
    - id: kielty2002
      authors: Kielty CM, Sherratt MJ, Shuttleworth CA
      year: 2002
      title: "Elastic fibres"
      journal: J Cell Sci 115(14):2817-2828
      doi: 10.1002/path.1107
      notes: >
        Elastic fiber architecture: tropoelastin monomers, microfibril
        scaffolds, lysyl oxidase cross-linking to desmosine. Supports
        elastin_crosslink_rate and recovery parameters.
    - id: almine2012
      authors: Almine JF, Wise SG, Weiss AS
      year: 2012
      title: "Elastin signaling in wound repair"
      journal: Birth Defects Res C Embryo Today 96(3):248-257
      doi: 10.1002/bdrc.21016
      notes: >
        Elastin fragments (matrikines) signal via elastin-binding protein
        to drive cell migration and protease production during repair.
        Covers temporal limitations of tropoelastin re-expression in scars.
    - id: mithieux2005
      authors: Mithieux SM, Weiss AS
      year: 2005
      title: "Elastin"
      journal: Adv Protein Chem 70:437-461
      doi: 10.1016/S0065-3233(05)70013-9
      notes: >
        Tropoelastin domain structure, coacervation, and elastic fiber
        assembly. Quantitative data on secretion and assembly rates.
        Supports elastin_recovery_rate parameter.

# ===========================================================================
# Cell mechanics and contact inhibition
# ===========================================================================

cell_mechanics:
  description: >
    Literature sources for cell-cell interaction forces and density-dependent
    growth control used in agent-based modeling.
  sources:
    - id: vanliedekerke2015
      authors: Van Liedekerke P, Palm MM, Jagiella N, Drasdo D
      year: 2015
      title: "Simulating tissue mechanics with agent-based models: concepts, perspectives and some novel results"
      journal: Comput Part Mech 2(4):401-444
      doi: 10.1007/s40571-015-0082-3
      notes: >
        JKR and Hertz contact models for deformable cell-cell interactions
        in agent-based tissue simulations. Supports cell_cell_force
        repulsion/adhesion calibration.
    - id: johnson1971
      authors: Johnson KL, Kendall K, Roberts AD
      year: 1971
      title: "Surface energy and the contact of elastic solids"
      journal: Proc R Soc Lond A 324(1558):301-313
      doi: 10.1098/rspa.1971.0141
      notes: >
        Original JKR theory for elastic contact with adhesion.
        Foundational reference for Hertz-adhesion cell force model.
    - id: eisenhoffer2012
      authors: Eisenhoffer GT, Loftus PD, Yoshigi M, Otsuna H, Chien CB, et al.
      year: 2012
      title: "Crowding induces live cell extrusion to maintain homeostatic cell numbers in epithelia"
      journal: Nature 484(7395):546-549
      doi: 10.1038/nature10999
      notes: >
        Epithelial overcrowding triggers live cell extrusion via
        stretch-activated channel Piezo1 and S1P signaling. Supports
        crowding-driven differentiation/extrusion threshold.

# ===========================================================================
# Scar remodeling (supplementary)
# ===========================================================================

scar_remodeling:
  description: >
    Additional literature for scar formation and collagen remodeling beyond
    the scar_formation dataset.
  sources:
    - id: xue2015
      authors: Xue M, Jackson CJ
      year: 2015
      title: "Extracellular matrix reorganization during wound healing and its impact on abnormal scarring"
      journal: Adv Wound Care 4(3):119-136
      doi: 10.1089/wound.2013.0485
      notes: >
        Collagen type III to type I transition during scar maturation.
        Lysyl oxidase cross-linking increases tensile strength over months.
        Supports scar accumulation model from collagen deposition.
    - id: bailey1998
      authors: Bailey AJ, Paul RG, Knott L
      year: 1998
      title: "Mechanisms of maturation and ageing of collagen"
      journal: Mech Ageing Dev 106(1-2):1-56
      doi: 10.1016/S0047-6374(98)00119-5
      notes: >
        Enzymatic (lysyl oxidase) and non-enzymatic (glycation) collagen
        cross-linking pathways. Divalent cross-links mature into stable
        multivalent forms. Reference for long-term scar maturation.
